|
AU2002952121A0
(en)
*
|
2002-10-17 |
2002-10-31 |
Alchemia Limited |
Novel carbohydrate based anti-bacterials
|
|
RS20050532A
(sr)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
GB0321996D0
(en)
*
|
2003-09-19 |
2003-10-22 |
Novartis Nutrition Ag |
Organic compounds
|
|
DE602004021831D1
(de)
†
|
2003-10-13 |
2009-08-13 |
Nestec Sa |
Mässigung der wirkung von endotoxinen
|
|
EP1634599A1
(en)
|
2004-08-20 |
2006-03-15 |
N.V. Nutricia |
Iimmune stimulatory infant nutrition
|
|
DK1629850T4
(da)
|
2004-08-24 |
2013-07-01 |
Nutricia Nv |
Næringssammensætning indeholdende ufordøjelige oligosaccharider
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
WO2007090894A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Nestec S.A. |
Oligosaccharide mixture
|
|
US20080208486A1
(en)
*
|
2006-03-23 |
2008-08-28 |
Jari Natunen |
Integrated System, Device and Use Thereof
|
|
JP5077623B2
(ja)
*
|
2006-03-30 |
2012-11-21 |
Ｄｉｃ株式会社 |
カシュー油変性固形フェノール樹脂の製造方法とゴム組成物
|
|
US20080071148A1
(en)
*
|
2006-04-03 |
2008-03-20 |
Massachusetts Institute Of Technology |
Glycomic patterns for the detection of disease
|
|
FI20060946A0
(fi)
*
|
2006-10-26 |
2006-10-26 |
Glykos Finland Oy |
Influenssaviruksen nukleiinihappoja ja peptidejä
|
|
FI20065800A0
(fi)
*
|
2006-12-13 |
2006-12-13 |
Glykos Finland Oy |
Polyvalentit biokonjugaatit
|
|
FI20075030A0
(fi)
*
|
2007-01-18 |
2007-01-18 |
Suomen Punainen Risti Veripalv |
Menetelmä solujen modifioimiseksi
|
|
FI20070471A0
(fi)
*
|
2007-06-13 |
2007-06-13 |
Glykos Finland Oy |
Ravinnelisäkompositiota
|
|
NZ581390A
(en)
*
|
2007-06-25 |
2012-09-28 |
Dsm Ip Assets Bv |
Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
|
|
MX2010002562A
(es)
*
|
2007-09-07 |
2011-04-11 |
Inst Nac De Ciencias Medicas Y Nutricion |
Uso de los niveles de antigeno secretor, de lewis y de sialilo como predictores para enfermedad.
|
|
ES2748136T3
(es)
|
2007-10-15 |
2020-03-13 |
United Animal Health Inc |
Método para aumentar el rendimiento de las crías
|
|
MY159076A
(en)
*
|
2007-11-08 |
2016-12-15 |
Nestec Sa |
Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
|
|
EP2265135B1
(en)
*
|
2008-03-14 |
2017-12-20 |
Nestec S.A. |
Synbiotic mixture
|
|
EP2143341A1
(en)
|
2008-07-08 |
2010-01-13 |
Nestec S.A. |
Nutritional Composition Containing Oligosaccharide Mixture
|
|
US8586029B2
(en)
*
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
GB0817908D0
(en)
*
|
2008-10-01 |
2008-11-05 |
Univ Ghent |
Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
|
|
JP5383692B2
(ja)
*
|
2008-10-10 |
2014-01-08 |
公益財団法人野口研究所 |
ピロリ菌増殖抑制剤
|
|
FI20080665A0
(fi)
|
2008-12-18 |
2008-12-18 |
Glykos Finland Oy |
Luonnollisen tyyppiset sakkaridikoostumukset
|
|
US20100311686A1
(en)
*
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
US8580278B2
(en)
|
2009-06-03 |
2013-11-12 |
Trustees Of Dartmouth College |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
FI20105824A0
(fi)
*
|
2010-07-26 |
2010-07-26 |
Suomen Punainen Risti Veripalv |
Veriryhmästatuksen käyttö IV
|
|
CN103221410B
(zh)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
Gpr119受体调节剂和对与其相关的障碍的治疗
|
|
DK2658399T4
(da)
*
|
2010-12-31 |
2024-03-25 |
Abbott Lab |
Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
|
|
US8795746B2
(en)
|
2011-02-16 |
2014-08-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic use of mucin glycans
|
|
JP6129821B2
(ja)
|
2011-05-13 |
2017-05-17 |
グリコシン リミテッド ライアビリティー カンパニー |
プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
|
|
US9539281B2
(en)
|
2011-07-12 |
2017-01-10 |
The Brigham And Women's Hospital, Inc. |
Lipid-containing PSA compositions, methods of isolation and methods of use thereof
|
|
EP2844301A2
(en)
*
|
2012-05-04 |
2015-03-11 |
Ineb-instituto de Engenharia Biomédica |
Microspheres for treating helicobacter pylori infections
|
|
US10626460B2
(en)
|
2013-02-21 |
2020-04-21 |
Children's Hospital Medical Center |
Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
|
|
EP2857410A1
(en)
*
|
2013-10-04 |
2015-04-08 |
Jennewein Biotechnologie GmbH |
Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
|
|
CN103622901B
(zh)
*
|
2013-11-21 |
2016-01-20 |
广州立白企业集团有限公司 |
一种能调节皮肤微生态平衡的皮肤清洁剂组合物及其制备方法
|
|
JP7158096B2
(ja)
|
2014-07-09 |
2022-10-21 |
カデナ バイオ，インコーポレーテッド |
オリゴ糖組成物及びその生成方法
|
|
AR104469A1
(es)
*
|
2014-08-08 |
2017-07-26 |
Glycovaxyn Ag |
Células huésped modificadas para su uso en producción de bioconjugados
|
|
CA3002540C
(en)
|
2015-01-06 |
2023-11-07 |
Arena Pharmaceuticals, Inc. |
Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
|
|
EP3862002A1
(en)
*
|
2015-01-26 |
2021-08-11 |
Kaleido Biosciences, Inc. |
Glycan therapeutics and related methods thereof
|
|
ES2755042T3
(es)
|
2015-01-26 |
2020-04-21 |
Cadena Bio Inc |
Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
|
|
MX378680B
(es)
|
2015-03-05 |
2025-03-11 |
Soc Des Produits Nestle S A Star |
Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
|
|
PT3264922T
(pt)
|
2015-03-05 |
2025-01-07 |
Nestle Sa |
Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
|
|
EP3285777B1
(en)
|
2015-04-23 |
2021-06-09 |
Kaleido Biosciences, Inc. |
Glycan therapeutics and methods of treatment
|
|
US10857167B2
(en)
|
2015-04-28 |
2020-12-08 |
Children's Hospital Medical Center |
Use of oligosaccharide compositions to enhance weight gain
|
|
JP6838744B2
(ja)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
|
|
CN108135167B
(zh)
|
2015-08-19 |
2021-07-09 |
哈佛学院院长及董事 |
脂化psa组合物和方法
|
|
CN105410913B
(zh)
*
|
2015-12-01 |
2018-06-01 |
辽宁三合酒业有限公司 |
一种壳寡糖口腔清洁含片的制备方法
|
|
WO2018014012A1
(en)
|
2016-07-15 |
2018-01-18 |
President And Fellows Of Harvard College |
Glycolipid compositions and methods of use
|
|
MX2018015187A
(es)
|
2016-08-04 |
2019-04-24 |
Nestec Sa |
Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
|
|
CN110520124A
(zh)
|
2017-02-16 |
2019-11-29 |
艾尼纳制药公司 |
用于治疗原发性胆汁性胆管炎的化合物和方法
|
|
US12090168B2
(en)
|
2017-11-03 |
2024-09-17 |
Dsm Nutritional Products, Llc |
Glucose glycans for treating urea cycle disorders
|
|
CN108018805B
(zh)
*
|
2017-12-31 |
2018-12-04 |
江苏来德福汽车部件有限公司 |
一种太阳能的智能移动护栏
|
|
JP7397011B2
(ja)
|
2018-06-06 |
2023-12-12 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１ｐ１受容体に関連する状態を治療する方法
|
|
EP3833195A1
(en)
*
|
2018-08-08 |
2021-06-16 |
Mars Incorporated |
Pet food products comprising oligosaccharides and methods of use
|
|
CN109212227B
(zh)
*
|
2018-09-07 |
2021-07-16 |
深圳格道糖生物技术有限公司 |
基于唾液特异糖蛋白糖链结构的肝病/肝硬化相关筛查、评估的产品及应用
|
|
WO2025083289A1
(en)
|
2023-10-19 |
2025-04-24 |
N.V. Nutricia |
Mixture of human milk oligosaccharides
|
|
CN122341284A
(zh)
|
2023-10-19 |
2026-07-03 |
纽迪希亚公司 |
人乳寡糖混合物
|